FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1980595945> ?p ?o ?g. }

• W1980595945 endingPage "41" @default.
• W1980595945 startingPage "37" @default.
• W1980595945 abstract "Background Children and young adults with recurrent or treatment-induced malignant gliomas have limited responses to temozolomide or oral VP-16 when either is administered as a single agent. We postulated that a combination of these two drugs for patients with recurrent or treatment-induced malignant gliomas might result in better and more prolonged responses. A retrospective analysis was performed on patients treated with the combination of temozolomide and VP-16. Procedure Eleven patients with recurrent or treatment-induced malignant gliomas were treated with varying combinations of temozolomide (150–210 mg/m2/d for 5 days) and oral VP-16 (50 mg/m2/d for 4–12 days). Responses were assessed by MRI scan, and data on clinical course and toxicity were retrospectively obtained from the medical record. Results The median age of the 11 patients was 17 years (range 5–23 years). Diagnoses included recurrent brain stem glioma (2), recurrent anaplastic astrocytoma (2), and glioblastoma (7) (3 treatment-induced, 2 malignant transformations of lower grade tumors, 1 recurrence, and 1 second tumor arising 10 months after diagnosis of medulloblastoma). All 11 patients had received radiotherapy (including 4 who received craniospinal radiation), and 7 had prior chemotherapy. Nine patients were treated at first recurrence, two at second recurrence. One patient had a complete response (CR), six had partial responses (PR), and four had progressive disease (PD). The median progression-free survival for the seven responding patients was 6 months (range 4–15+ months). There was one grade 4 neutropenia, but no other grade 3 or 4 toxicities. Conclusions These data suggest there is activity of temozolomide in combination with oral VP-16 for children and young adults with recurrent malignant gliomas. © 2005 Wiley-Liss, Inc." @default.
• W1980595945 created "2016-06-24" @default.
• W1980595945 creator A5027769573 @default.
• W1980595945 creator A5044892740 @default.
• W1980595945 creator A5050835183 @default.
• W1980595945 creator A5068257880 @default.
• W1980595945 date "2006-01-01" @default.
• W1980595945 modified "2023-09-23" @default.
• W1980595945 title "Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas" @default.
• W1980595945 cites W1722373994 @default.
• W1980595945 cites W1884303117 @default.
• W1980595945 cites W1929532369 @default.
• W1980595945 cites W1933116774 @default.
• W1980595945 cites W1959628099 @default.
• W1980595945 cites W1968945237 @default.
• W1980595945 cites W1975129619 @default.
• W1980595945 cites W1977392502 @default.
• W1980595945 cites W1978359045 @default.
• W1980595945 cites W2004276356 @default.
• W1980595945 cites W2011953333 @default.
• W1980595945 cites W2025791816 @default.
• W1980595945 cites W2040275378 @default.
• W1980595945 cites W2040944375 @default.
• W1980595945 cites W2055159778 @default.
• W1980595945 cites W2060466114 @default.
• W1980595945 cites W2065190422 @default.
• W1980595945 cites W2082302274 @default.
• W1980595945 cites W2113911127 @default.
• W1980595945 cites W2129321468 @default.
• W1980595945 cites W2140172557 @default.
• W1980595945 cites W2156976216 @default.
• W1980595945 cites W2164730927 @default.
• W1980595945 cites W2168843129 @default.
• W1980595945 cites W2263652370 @default.
• W1980595945 cites W235444781 @default.
• W1980595945 doi "https://doi.org/10.1002/pbc.20510" @default.
• W1980595945 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16047359" @default.
• W1980595945 hasPublicationYear "2006" @default.
• W1980595945 type Work @default.
• W1980595945 sameAs 1980595945 @default.
• W1980595945 citedByCount "25" @default.
• W1980595945 countsByYear W19805959452012 @default.
• W1980595945 countsByYear W19805959452013 @default.
• W1980595945 countsByYear W19805959452015 @default.
• W1980595945 countsByYear W19805959452016 @default.
• W1980595945 countsByYear W19805959452018 @default.
• W1980595945 countsByYear W19805959452019 @default.
• W1980595945 countsByYear W19805959452020 @default.
• W1980595945 crossrefType "journal-article" @default.
• W1980595945 hasAuthorship W1980595945A5027769573 @default.
• W1980595945 hasAuthorship W1980595945A5044892740 @default.
• W1980595945 hasAuthorship W1980595945A5050835183 @default.
• W1980595945 hasAuthorship W1980595945A5068257880 @default.
• W1980595945 hasConcept C126322002 @default.
• W1980595945 hasConcept C141071460 @default.
• W1980595945 hasConcept C142724271 @default.
• W1980595945 hasConcept C143998085 @default.
• W1980595945 hasConcept C2776694085 @default.
• W1980595945 hasConcept C2777063308 @default.
• W1980595945 hasConcept C2777389519 @default.
• W1980595945 hasConcept C2778227246 @default.
• W1980595945 hasConcept C2778880634 @default.
• W1980595945 hasConcept C2779083369 @default.
• W1980595945 hasConcept C2780789225 @default.
• W1980595945 hasConcept C502942594 @default.
• W1980595945 hasConcept C509974204 @default.
• W1980595945 hasConcept C71924100 @default.
• W1980595945 hasConcept C90924648 @default.
• W1980595945 hasConceptScore W1980595945C126322002 @default.
• W1980595945 hasConceptScore W1980595945C141071460 @default.
• W1980595945 hasConceptScore W1980595945C142724271 @default.
• W1980595945 hasConceptScore W1980595945C143998085 @default.
• W1980595945 hasConceptScore W1980595945C2776694085 @default.
• W1980595945 hasConceptScore W1980595945C2777063308 @default.
• W1980595945 hasConceptScore W1980595945C2777389519 @default.
• W1980595945 hasConceptScore W1980595945C2778227246 @default.
• W1980595945 hasConceptScore W1980595945C2778880634 @default.
• W1980595945 hasConceptScore W1980595945C2779083369 @default.
• W1980595945 hasConceptScore W1980595945C2780789225 @default.
• W1980595945 hasConceptScore W1980595945C502942594 @default.
• W1980595945 hasConceptScore W1980595945C509974204 @default.
• W1980595945 hasConceptScore W1980595945C71924100 @default.
• W1980595945 hasConceptScore W1980595945C90924648 @default.
• W1980595945 hasIssue "1" @default.
• W1980595945 hasLocation W19805959451 @default.
• W1980595945 hasLocation W19805959452 @default.
• W1980595945 hasOpenAccess W1980595945 @default.
• W1980595945 hasPrimaryLocation W19805959451 @default.
• W1980595945 hasRelatedWork W1979262700 @default.
• W1980595945 hasRelatedWork W1991181901 @default.
• W1980595945 hasRelatedWork W1997541085 @default.
• W1980595945 hasRelatedWork W2134519610 @default.
• W1980595945 hasRelatedWork W2152636851 @default.
• W1980595945 hasRelatedWork W2158789712 @default.
• W1980595945 hasRelatedWork W2262493723 @default.
• W1980595945 hasRelatedWork W2406432714 @default.
• W1980595945 hasRelatedWork W2520617406 @default.
• W1980595945 hasRelatedWork W59994307 @default.

• next